1. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore). 1992; 71:109–120. PMID:
1635436.
Article
2. McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J. 1967; 1:451–455. PMID:
6017520.
Article
3. Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr, McManis PG. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989; 149:2597–2600. PMID:
2818118.
Article
4. Lee JI, Sohn TS, Son HS, Oh SJ, Kwon HS, Chang SA, et al. Thyrotoxic periodic paralysis presenting as polymorphic ventricular tachycardia induced by painless thyroiditis. Thyroid. 2009; 19:1433–1434. PMID:
20001723.
Article
5. Miller JD, Quillian W, Cleveland WW. Nonfamilial hypokalemic periodic paralysis and thyrotoxicosis in a 16-year-old male. Pediatrics. 1997; 100(3 Pt 1):412. PMID:
9282719.
Article
6. Wong GW, Leung TF, Lo AF, Ahuja AT, Cheng PS. Thyrotoxic periodic paralysis in a 14-year-old boy. Eur J Pediatr. 2000; 159:934. PMID:
11131357.
Article
7. Oh KW, Jeong JY, Kim JS. A case of thyrotoxic periodic paralysis in adolescent with Graves' disease. J Korean Soc Pediatr Endocrinol. 2011; 16:196–200.
Article
8. Ahn MB, Jung YJ, Lee MH, Cho WK, Suh BK. A case of thyrotoxic periodic paralysis in a 16-year-old adolescent. Ann Pediatr Endocrinol Metab. 2012; 17:117–121.
Article
9. Azuma KK, Hensley CB, Tang MJ, McDonough AA. Thyroid hormone specifically regulates skeletal muscle Na(+)-K(+)-ATPase alpha 2- and beta 2-isoforms. Am J Physiol. 1993; 265(3 Pt 1):C680–C687. PMID:
8214025.
Article
10. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ. 1991; 303:1096–1099. PMID:
1660744.
Article
11. Kjeldsen K, Norgaard A, Gotzsche CO, Thomassen A, Clausen T. Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet. 1984; 2:8–10. PMID:
6145984.
Article
12. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis. 2001; 37:620–623. PMID:
11228188.
Article
13. Guerra M, Rodriguez del Castillo A, Battaner E, Mas M. Androgens stimulate preoptic area Na
+, K
+-ATPase activity in male rats. Neurosci Lett. 1987; 78:97–100. PMID:
3039424.
14. Kung AW. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006; 91:2490–2495. PMID:
16608889.
15. Chang CC, Cheng CJ, Sung CC, Chiueh TS, Lee CH, Chau T, et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol. 2013; 169:529–536. PMID:
23939916.
Article
16. Trifanescu RA, Danciulescu Miulescu R, Carsote M, Poiana C. Hypokalemic periodic paralysis as first sign of thyrotoxicosis. J Med Life. 2013; 6:72–75. PMID:
23599824.
17. Valizadeh N, Zarrin S. A 32-year-old man with normokalemic thyrotoxic periodic paralysis. Malays J Med Sci. 2013; 20:81–83. PMID:
23613659.
18. Lin SH, Chiu JS, Hsu CW, Chau T. A simple and rapid approach to hypokalemic paralysis. Am J Emerg Med. 2003; 21:487–491. PMID:
14574658.
Article
19. Ahmed I, Chilimuri SS. Fatal dysrhythmia following potassium replacement for hypokalemic periodic paralysis. West J Emerg Med. 2010; 11:57–59. PMID:
20411077.
20. Cope TE, Samaraweera AP, Burn DJ. Thyrotoxic periodic paralysis: correct hypokalemia with caution. J Emerg Med. 2013; 45:338–340. PMID:
23849367.
Article